-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Solid Biosciences, Raises Price Target to $12

Benzinga·03/25/2026 14:35:50
Listen to the news
JP Morgan analyst Anupam Rama maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $11 to $12.